Pimavanserin (Nuplazid)

Pimavanserin (Tradename: Nuplazid) is an antipsychotic in the atypical antipsychotic class used in the treatment of Parkinson's disease psychosis in the United States. It is not yet approved in Canada.

• Second-Generation (Atypical) Antipsychotics
• Risperidone (Risperdal)
• Paliperidone (Invega)
• Aripiprazole (Abilify)
• Brexpiprazole (Rexulti)
• Cariprazine (Vraylar)
• Olanzapine (Zyprexa)
• Ziprasidone (Zeldox/Geodon)
• Lurasidone (Latuda)
• Quetiapine (Seroquel)
• Clozapine (Clozaril)
• Amisulpride (Solian)
• Pimavanserin (Nuplazid)
• Asenapine (Saphris)